EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 42, Issue 12, 2015, Pages 1929-1940

  Verberne, Hein J ^a   Acampa, Wanda ^b   Anagnostopoulos, Constantinos ^c   Ballinger, Jim ^d   Bengel, Frank ^e   De Bondt, Pieter ^f   Buechel, Ronny R ^g   Cuocolo, Alberto ^h   van Eck Smit, Berthe L F ^a   Flotats, Albert ⁱ   Hacker, Marcus ^j   Hindorf, Cecilia ^k   Kaufmann, Philip A ^g   Lindner, Oliver ^l   Ljungberg, Michael ^m   Lonsdale, Markus ⁿ   Manrique, Alain ^o   Minarik, David ^k   Scholte, Arthur J H A ^p   Slart, Riemer H J A ^q   Trägårdh, Elin ^k   de Wit, Tim C ^a   Hesse, Birger ^r   more..

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CNR   (Italy)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^d GUY S HOSPITAL   (United Kingdom)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f OLV HOSPITAL   (Belgium)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k LUND UNIVERSITY HOSPITAL   (Sweden)

^l RUHR UNIVERSITY BOCHUM   (Germany)

^m LUND UNIVERSITY   (Sweden)

ⁿ BISPEBJERG HOSPITAL   (Denmark)

^o CAEN UNIVERSITY HOSPITAL   (France)

^p LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^q UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^r Rigshospitalet   (Denmark)

more..

Author keywords

Guidelines; Myocardial perfusion imaging; Nuclear medicine; Procedures

Indexed keywords

CONTRAST MEDIUM; REGADENOSON; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; VASODILATOR AGENT;

ARTICLE; BRONCHOSPASM; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CONVULSION; DATA ANALYSIS; DIZZINESS; DRUG ERUPTION; DRUG SAFETY; EXERCISE; FACE EDEMA; FAINTNESS; FORCED EXPIRATORY VOLUME; HEADACHE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE PERFUSION; HOT FLUSH; HUMAN; HYPOTENSION; JAW PAIN; KIDNEY DYSFUNCTION; LARYNX EDEMA; LUNG EDEMA; MYOCARDIAL PERFUSION IMAGING; NAUSEA; NECK PAIN; PRACTICE GUIDELINE; PRURITUS; RADIATION EXPOSURE; RADIONUCLIDE MYOCARDIAL PERFUSION IMAGING; RESPIRATORY ARREST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SORE THROAT; SPECT SCANNER; THORAX PAIN; THYROTOXICOSIS; URTICARIA; VOMITING; ADULT; ADVERSE EFFECTS; CORONARY ARTERY DISEASE; DEVICES; DIAGNOSTIC IMAGING; DOSE RESPONSE; IMAGE PROCESSING; MALE; MEDICAL SOCIETY; MIDDLE AGED; MULTIMODAL IMAGING; PATHOPHYSIOLOGY; PROCEDURES; SAFETY; SOFTWARE; X-RAY COMPUTED TOMOGRAPHY;

ADULT; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDIAL PERFUSION IMAGING; PRACTICE GUIDELINES AS TOPIC; PURINES; PYRAZOLES; RADIATION EXPOSURE; SAFETY; SOCIETIES, MEDICAL; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED; VASODILATOR AGENTS;

EID: 84942989815     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-015-3139-x     Document Type: Article

References (80)

1. Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, De Bondt P, et al. 2015 updated EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT. http://eanm.org/publications/guidelines/2015_07_EANM_FINAL_myocardial_perfusion_guideline.pdf. 2015. Accessed 7 July 2015.
2. Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005;32(7):855–97.
3. Hesse B, Lindhardt TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, et al. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging. 2008;35(4):851–85.
4. Flotats A, Knuuti J, Gutberlet M, Marcassa C, Bengel FM, Kaufmann PA, et al. Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging. 2011;38(1):201–12.
5. Zoghbi GJ, Iskandrian AE. Selective adenosine agonists and myocardial perfusion imaging. J Nucl Cardiol. 2012;19(1):126–41.
6. Bonello L, Laine M, Kipson N, Mancini J, Helal O, Fromonot J, et al. Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome. J Am Coll Cardiol. 2014;63(9):872–7.
7. Voci P, Pizzuto F. Coronary flow reserve with a turbo: a warning for the use of adenosine as a provocative test in patients receiving ticagrelor? J Am Coll Cardiol. 2014;63(9):878–9.
8. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14(5):645–58.
9. Mahmarian JJ, Cerqueira MD, Iskandrian AE, Bateman TM, Thomas GS, Hendel RC, et al. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging. 2009;2(8):959–68.
10. Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2004;11(5):551–61.
11. Brinkert M, Reyes E, Walker S, Latus K, Maenhout A, Mizumoto R, et al. Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy. Eur J Nucl Med Mol Imaging. 2014;41(3):511–21.
12. Thomas GS, Prill NV, Majmundar H, Fabrizi RR, Thomas JJ, Hayashida C, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol. 2000;7(5):439–46.
13. Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging. 2008;1(3):307–16.
14. Leaker BR, O’Connor B, Hansel TT, Barnes PJ, Meng L, Mathur VS, et al. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol. 2008;15(3):329–36.
15. Thomas GS, Tammelin BR, Schiffman GL, Marquez R, Rice DL, Milikien D, et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol. 2008;15(3):319–28.
16. Agarwal V, DePuey EG. Regadenoson and seizures: a real clinical concern. J Nucl Cardiol. 2014;21(5):869–70.
17. Fukuda M, Suzuki Y, Hino H, Morimoto T, Ishii E. Activation of central adenosine A(2A) receptors lowers the seizure threshold of hyperthermia-induced seizure in childhood rats. Seizure. 2011;20(2):156–9.
18. Page 2nd RL, Spurck P, Bainbridge JL, Michalek J, Quaife RA. Seizures associated with regadenoson: a case series. J Nucl Cardiol. 2012;19(2):389–91.
19. Hage FG. Regadenoson for myocardial perfusion imaging: is it safe? J Nucl Cardiol. 2014;21(5):871–6.
20. Pharmacovigilance Risk Assessment Committee (PRAC), Minutes of the meeting on 5–8 May 2014. http://www.ema.europa.eu/docs/en_GB/document_library/Minutes/2014/06/WC500169468.pdf. 2014. Accessed 7 July 2015.
21. ICRP. Human alimentary tract model for radiological protection. ICRP Publication 100. A report of The International Commission on Radiological Protection. Ann ICRP. 2006;36(1-2):25–327. iii.
22. ICRP. The 2007 Recommendations of the International Commission on radiological protection. ICRP publication 103. Ann ICRP. 2007;37(2-4):1–332.
23. ICRP. Adult reference computational phantoms. ICRP Publication 110. Ann ICRP. 2009;39(2).
24. Andersson M, Johansson L, Minarik D, Leide-Svegborn S, Mattsson S. Effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors. EJNMMI Phys. 2014;1(1):9.
25. Duvall WL, Croft LB, Ginsberg ES, Einstein AJ, Guma KA, George T, et al. Reduced isotope dose and imaging time with a high-efficiency CZT SPECT camera. J Nucl Cardiol. 2011;18(5):847–57.
26. Herzog BA, Buechel RR, Katz R, Brueckner M, Husmann L, Burger IA, et al. Nuclear myocardial perfusion imaging with a cadmium-zinc-telluride detector technique: optimized protocol for scan time reduction. J Nucl Med. 2010;51(1):46–51.
27. Nkoulou R, Pazhenkottil AP, Kuest SM, Ghadri JR, Wolfrum M, Husmann L, et al. Semiconductor detectors allow low-dose-low-dose 1-day SPECT myocardial perfusion imaging. J Nucl Med. 2011;52(8):1204–9.
28. Oddstig J, Hedeer F, Jogi J, Carlsson M, Hindorf C, Engblom H. Reduced administered activity, reduced acquisition time, and preserved image quality for the new CZT camera. J Nucl Cardiol. 2013;20(1):38–44.
29. Sharir T, Ben-Haim S, Merzon K, Prochorov V, Dickman D, Ben-Haim S, et al. High-speed myocardial perfusion imaging initial clinical comparison with conventional dual detector anger camera imaging. JACC Cardiovasc Imaging. 2008;1(2):156–63.
30. Lassmann M. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging. 2008;35(9):1748.
31. Buechel RR, Husmann L, Herzog BA, Pazhenkottil AP, Nkoulou R, Ghadri JR, et al. Low-dose computed tomography coronary angiography with prospective electrocardiogram triggering: feasibility in a large population. J Am Coll Cardiol. 2011;57(3):332–6.
32. Maruyama T, Takada M, Hasuike T, Yoshikawa A, Namimatsu E, Yoshizumi T. Radiation dose reduction and coronary assessability of prospective electrocardiogram-gated computed tomography coronary angiography: comparison with retrospective electrocardiogram-gated helical scan. J Am Coll Cardiol. 2008;52(18):1450–5.
33. Achenbach S, Marwan M, Ropers D, Schepis T, Pflederer T, Anders K, et al. Coronary computed tomography angiography with a consistent dose below 1 mSv using prospectively electrocardiogram-triggered high-pitch spiral acquisition. Eur Heart J. 2010;31(3):340–6.
34. Fuchs TA, Stehli J, Bull S, Dougoud S, Clerc OF, Herzog BA, et al. Coronary computed tomography angiography with model-based iterative reconstruction using a radiation exposure similar to chest X-ray examination. Eur Heart J. 2014;35(17):1131–6.
35. DePuey EG. Advances in SPECT camera software and hardware: currently available and new on the horizon. J Nucl Cardiol. 2012;19(3):551–81. quiz 85.
36. Garcia EV, Faber TL, Esteves FP. Cardiac dedicated ultrafast SPECT cameras: new designs and clinical implications. J Nucl Med. 2011;52(2):210–7.
37. Hutton BF. Developments in cardiac-specific SPECT imaging. Q J Nucl Med Mol Imaging. 2012;56(3):221–9.
38. Einstein AJ, Blankstein R, Andrews H, Fish M, Padgett R, Hayes SW, et al. Comparison of image quality, myocardial perfusion, and left ventricular function between standard imaging and single-injection ultra-low-dose imaging using a high-efficiency SPECT camera: the MILLISIEVERT study. J Nucl Med. 2014;55(9):1430–7.
39. Ben-Haim S, Almukhailed O, Neill J, Slomka P, Allie R, Shiti D, et al. Clinical value of supine and upright myocardial perfusion imaging in obese patients using the D-SPECT camera. J Nucl Cardiol. 2014;21(3):8.
40. Chawla D, Rahaby M, Amin AP, Vashistha R, Alyousef T, Martinez HX, et al. Soft tissue attenuation patterns in stress myocardial perfusion SPECT images: a comparison between supine and upright acquisition systems. J Nucl Cardiol. 2011;18(2):281–90.
41. Abbara S, Arbab-Zadeh A, Callister TQ, Desai MY, Mamuya W, Thomson L, et al. SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2009;3(3):190–204.
42. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure guideline for SPECT/CT imaging 1.0. J Nucl Med. 2006;47(7):1227–34.
43. Utsunomiya D, Nakaura T, Honda T, Shiraishi S, Tomiguchi S, Kawanaka K, et al. Object-specific attenuation correction at SPECT/CT in thorax: optimization of respiratory protocol for image registration. Radiology. 2005;237(2):662–9.
44. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Grople RJ, et al. PET myocardial perfusion and metabolism clinical imaging. http://www.asnc.org/imageuploads/ImagingGuidelinesPET. 2008. Accessed 7 July 2015.
45. Lehner S, Sussebach C, Todica A, Uebleis C, Brunner S, Bartenstein P, et al. Influence of SPECT attenuation correction on the quantification of hibernating myocardium as derived from combined myocardial perfusion SPECT and (1)(8)F-FDG PET. J Nucl Cardiol. 2014;21(3):578–87.
46. Einstein AJ, Johnson LL, Bokhari S, Son J, Thompson RC, Bateman TM, et al. Agreement of visual estimation of coronary artery calcium from low-dose CT attenuation correction scans in hybrid PET/CT and SPECT/CT with standard Agatston score. J Am Coll Cardiol. 2010;56(23):1914–21.
47. Burkhard N, Herzog BA, Husmann L, Pazhenkottil AP, Burger IA, Buechel RR, et al. Coronary calcium score scans for attenuation correction of quantitative PET/CT 13N-ammonia myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2010;37(3):517–21.
48. Schepis T, Gaemperli O, Koepfli P, Ruegg C, Burger C, Leschka S, et al. Use of coronary calcium score scans from stand-alone multislice computed tomography for attenuation correction of myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging. 2007;34(1):11–9.
49. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359(22):2324–36.
50. Vavere AL, Arbab-Zadeh A, Rochitte CE, Dewey M, Niinuma H, Gottlieb I, et al. Coronary artery stenoses: accuracy of 64-detector row CT angiography in segments with mild, moderate, or severe calcification—a subanalysis of the CORE-64 trial. Radiology. 2011;261(1):100–8.
51. ACR–NASCI–SPR Practice guideline for the performance and interpretation of cardiac computed tomography. http://www.acr.org/~/media/f4720a18f03b4a26a0c9c3cc18637d87.pdf. 2011. Accessed 7 July 2015.
52. Lembcke A, Schwenke C, Hein PA, Knobloch G, Durmus T, Hamm B, et al. High-pitch dual-source CT coronary angiography with low volumes of contrast medium. Eur Radiol. 2014;24(1):120–7.
53. Hoffmann U, Ferencik M, Cury RC, Pena AJ. Coronary CT angiography. J Nucl Med. 2006;47(5):797–806.
54. Schroeder S, Achenbach S, Bengel F, Burgstahler C, Cademartiri F, de Feyter P, et al. Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. Eur Heart J. 2008;29(4):531–56.
55. ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media, Version 9, 2013. http://www.acr.org/quality-safety/resources/~/media/37D84428BF1D4E1B9A3A2918DA9E27A3.pdf/. 2013. Accessed 7 July 2015.
56. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328–54.
57. Schopp JG, Iyer RS, Wang CL, Petscavage JM, Paladin AM, Bush WH, et al. Allergic reactions to iodinated contrast media: premedication considerations for patients at risk. Emerg Radiol. 2013;20(4):299–306.
58. Thomsen HS. Contrast media safety-an update. Eur J Radiol. 2011;80(1):77–82.
59. Cochran ST, Bomyea K, Sayre JW. Trends in adverse events after IV administration of contrast media. AJR Am J Roentgenol. 2001;176(6):1385–8.
60. Mortele KJ, Oliva MR, Ondategui S, Ros PR, Silverman SG. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol. 2005;184(1):31–4.
61. Wang CL, Cohan RH, Ellis JH, Caoili EM, Wang G, Francis IR. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol. 2008;191(2):409–15.
62. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990;175(3):621–8.
63. Kaufmann PA. Cardiac hybrid imaging: state-of-the-art. Ann Nucl Med. 2009;23(4):325–31.
64. Raff GL, Abidov A, Achenbach S, Berman DS, Boxt LM, Budoff MJ, et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr. 2009;3(2):122–36.
65. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105(4):539–42.
66. Javadi MS, Lautamaki R, Merrill J, Voicu C, Epley W, McBride G, et al. Definition of vascular territories on myocardial perfusion images by integration with true coronary anatomy: a hybrid PET/CT analysis. J Nucl Med. 2010;51(2):198–203.
67. Gaemperli O, Bengel FM, Kaufmann PA. Cardiac hybrid imaging. Eur Heart J. 2011;32(17):2100–8.
68. Gaemperli O, Schepis T, Valenta I, Husmann L, Scheffel H, Duerst V, et al. Cardiac image fusion from stand-alone SPECT and CT: clinical experience. J Nucl Med. 2007;48(5):696–703.
69. Santana CA, Garcia EV, Faber TL, Sirineni GK, Esteves FP, Sanyal R, et al. Diagnostic performance of fusion of myocardial perfusion imaging (MPI) and computed tomography coronary angiography. J Nucl Cardiol. 2009;16(2):201–11.
70. Slomka PJ, Baum RP. Multimodality image registration with software: state-of-the-art. Eur J Nucl Med Mol Imaging. 2009;36 Suppl 1:S44–55.
71. Slomka PJ. Software approach to merging molecular with anatomic information. J Nucl Med. 2004;45 Suppl 1:36s–45.
72. Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008;52(21):1724–32.
73. Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA, et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol. 2008;52(25):2135–44.
74. Husmann L, Tatsugami F, Aepli U, Herzog BA, Valenta I, Veit-Haibach P, et al. Prevalence of noncardiac findings on low dose 64-slice computed tomography used for attenuation correction in myocardial perfusion imaging with SPECT. Int J Cardiovasc Imaging. 2009;25(8):859–65.
75. Rispler S, Keidar Z, Ghersin E, Roguin A, Soil A, Dragu R, et al. Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J Am Coll Cardiol. 2007;49(10):1059–67.
76. Sato A, Nozato T, Hikita H, Miyazaki S, Takahashi Y, Kuwahara T, et al. Incremental value of combining 64-slice computed tomography angiography with stress nuclear myocardial perfusion imaging to improve noninvasive detection of coronary artery disease. J Nucl Cardiol. 2010;17(1):19–26.
77. Pazhenkottil AP, Nkoulou RN, Ghadri JR, Herzog BA, Buechel RR, Kuest SM, et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart J. 2011;32(12):1465–71.
78. van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Boersma E, Wijns W, et al. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol. 2009;53(7):623–32.
79. Pazhenkottil AP, Nkoulou RN, Ghadri JR, Herzog BA, Kuest SM, Husmann L, et al. Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease. Eur Heart J. 2011;32(22):2824–9.
80. Fiechter M, Ghadri JR, Wolfrum M, Kuest SM, Pazhenkottil AP, Nkoulou RN, et al. Downstream resource utilization following hybrid cardiac imaging with an integrated cadmium-zinc-telluride/64-slice CT device. Eur J Nucl Med Mol Imaging. 2012;39(3):430–6.